Browse by Medical Category
Accepting New Patients
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Hsinlin Thomas Cheng, M.D. Ph.D. specializes in both adult Neurology and Pain Medicine. Dr. Cheng treats patients suffered from headache to other neuropathic pain syndromes. Dr. Cheng earned his medical degree in 1991 from the Taipei Medical University in Taipei, Taiwan. After completing his doctoral program of Neuroscience in 1996 at the University of Michigan, he completed his residency in the Department of Neurology at Wayne State University before taking on a clinical fellowship at the Memorial Sloan Kettering Cancer Center and a research fellowship at the Weill Medical College at Cornell University from 2004-06. Dr. Cheng returned to the University of Michigan as Assistant Professor in the Department of Neurology from 2006-13. Dr. Cheng joined the Department of Neurology at Massachusetts General Hospital in July, 2013.
Dr. Cheng is a member of the Society for Neuroscience, American Pain Society, and American Academy of Neurology. He is a fellow of American Neurological Association. He is a recipient for a NIH KO8 award. Previously, he was a recipient of a Fellowship Training Grant from the National Cancer Institute from 2004-06, he received a Neuroscience Student Publication Award from the U-M in 1996 and a Travel Award from the American Pain Society in 2005. He was awarded Wolfe Research Prize by the American Neurological Association in 2010.
Dr. Cheng's research interests are in studying the mechanisms of pain. He is funded by the National Institute of Health to study the molecular mechanisms of painful diabetic neuropathy. He has discovered multiple pain molecules activated in an animal model of type 2 diabetes. His research has been published by numerous peer-reviewed scientific journals and reported in many conferences. His findings provide better understanding for the mechanisms of painful diabetic neuropathy and could lead to the development for the future treatments for this devastating disease.
Back to Top